Emerging nanomedicines of paclitaxel for cancer treatmentJOURNAL OF CONTROLLED RELEASEIF11.52022-02-0152PRE
Dimeric prodrug-based nanomedicines for cancer therapyJOURNAL OF CONTROLLED RELEASEIF11.52020-10-0185PREAI
Ferroptosis-driven nanotherapeutics for cancer treatment铁死亡驱动的纳米疗法用于癌症治疗JOURNAL OF CONTROLLED RELEASEIF11.52020-03-01158PREAI
Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxelASIAN JOURNAL OF PHARMACEUTICAL SCIENCESIF11.92019-09-0120OAAI
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy用于协同化学光动力疗法的异型二聚体的自促进ROS响应纳米组装JOURNAL OF CONTROLLED RELEASEIF11.52019-05-01126PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向